EMAIL THIS PAGE TO A FRIEND

Journal of virology

Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.


PMID 24920803

Abstract

The ability of human cytomegalovirus (HCMV) to establish lifelong persistence and reactivate from latency is critical to its success as a pathogen. Here we describe a short-term in vitro model representing the events surrounding HCMV latency and reactivation in circulating peripheral blood monocytes that was developed in order to study the immunological consequence of latent virus carriage. Infection of human CD14(+) monocytes by HCMV resulted in the immediate establishment of latency, as evidenced by the absence of particular lytic gene expression, the transcription of latency-associated mRNAs, and the maintenance of viral genomes. Latent HCMV induced cellular differentiation to a macrophage lineage, causing production of selective proinflammatory cytokines and myeloid-cell chemoattractants that most likely play a role in virus dissemination in the host. Analysis of global cellular gene expression revealed activation of innate immune responses and the modulation of protein and lipid synthesis to accommodate latent HCMV infection. Remarkably, monocytes harboring latent virus exhibited selective responses to secondary stimuli known to induce an antiviral state. Furthermore, when challenged with type I and II interferon, latently infected cells demonstrated a blockade of signaling at the level of STAT1 phosphorylation. The data demonstrate that HCMV reprograms specific cellular pathways in monocytes, most notably innate immune responses, which may play a role in the establishment of, maintenance of, and reactivation from latency. The modulation of innate immune responses is likely a viral evasion strategy contributing to viral dissemination and pathogenesis in the host. HCMV has the ability to establish a lifelong infection within the host, a phenomenon termed latency. We have established a short-term model system in human peripheral blood monocytes to study the immunological relevance of latent virus carriage. Infection of CD14(+) monocytes by HCMV results in the generation of latency-specific transcripts, maintenance of viral genomes, and the capacity to reenter the lytic cycle. During short-term latency in monocytes the virus initiates a program of differentiation to inflammatory macrophages that coincides with the modulation of cytokine secretion and specific cellular processes. HCMV-infected monocytes are hindered in their capacity to exert normal immunoprotective mechanisms. Additionally, latent virus disrupts type I and II interferon signaling at the level of STAT1 phosphorylation. This in vitro model system can significantly contribute to our understanding of the molecular and inflammatory factors that initiate HCMV reactivation in the host and allow the development of strategies to eradicate virus persistence.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1105169 Anti-STAT1 (671-685) antibody produced in rabbit, IgG fraction of antiserum
SAB4300326
Anti-STAT1 (Ab-701) antibody produced in rabbit, affinity isolated antibody
SAB4300441
Anti-STAT1 (Ab-727) antibody produced in rabbit, affinity isolated antibody
GW22758 Anti-STAT1 (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
AV33373
Anti-STAT1 (AB1) antibody produced in rabbit, affinity isolated antibody
GW22780 Anti-STAT1 (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
AV33374
Anti-STAT1 (AB2) antibody produced in rabbit, affinity isolated antibody
AV38933
Anti-STAT1 (AB3) antibody produced in rabbit, affinity isolated antibody
AV38934
Anti-STAT1 (AB4) antibody produced in rabbit, affinity isolated antibody
SAB1406486
Anti-STAT1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA000931
Anti-STAT1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV36979
Anti-STAT1 antibody produced in rabbit, IgG fraction of antiserum
S5683 Anti-STAT1 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous glycerol solution
HPA000982
Anti-STAT1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0006772M1
Monoclonal Anti-STAT1 antibody produced in mouse, clone 1A8, purified immunoglobulin, buffered aqueous solution